[go: up one dir, main page]

DK162130C - GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES - Google Patents

GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES

Info

Publication number
DK162130C
DK162130C DK151884A DK151884A DK162130C DK 162130 C DK162130 C DK 162130C DK 151884 A DK151884 A DK 151884A DK 151884 A DK151884 A DK 151884A DK 162130 C DK162130 C DK 162130C
Authority
DK
Denmark
Prior art keywords
grf
analog peptides
grf analog
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK151884A
Other languages
Danish (da)
Other versions
DK162130B (en
DK151884D0 (en
DK151884A (en
Inventor
Arthur M Felix
Edgar P Heimer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK151884D0 publication Critical patent/DK151884D0/en
Publication of DK151884A publication Critical patent/DK151884A/en
Publication of DK162130B publication Critical patent/DK162130B/en
Application granted granted Critical
Publication of DK162130C publication Critical patent/DK162130C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE Polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide. 1. Claims for the Contracting State : AT A method for the preparation of polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide, characterized in that (a) the protecting groups of a protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the liquid phase method, are cleaved off in a manner known per se, or (b) a carrier resin-bound protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the solid phase method, is treated with anhydrous liquid HF.
DK151884A 1983-03-07 1984-03-05 GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES DK162130C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47270083A 1983-03-07 1983-03-07
US47270083 1983-03-07

Publications (4)

Publication Number Publication Date
DK151884D0 DK151884D0 (en) 1984-03-05
DK151884A DK151884A (en) 1984-09-08
DK162130B DK162130B (en) 1991-09-23
DK162130C true DK162130C (en) 1992-03-02

Family

ID=23876594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK151884A DK162130C (en) 1983-03-07 1984-03-05 GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES

Country Status (11)

Country Link
EP (1) EP0121764B1 (en)
JP (1) JPH0786120B2 (en)
AT (1) ATE53220T1 (en)
AU (1) AU574064B2 (en)
CA (1) CA1254000A (en)
DE (1) DE3482387D1 (en)
DK (1) DK162130C (en)
IE (1) IE57097B1 (en)
IL (1) IL71150A (en)
NZ (1) NZ207378A (en)
ZA (1) ZA841638B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio- Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
DE3327007A1 (en) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt PRODUCTION OF POLYPEPTIDES WITH AN ACID-CARBOXYTERMINUS
AU575843B2 (en) * 1983-08-10 1988-08-11 The Administrators Of The Tulane Eductional Fund Growth hormone releasing peptides
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
US4734399A (en) * 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
EP0212531A1 (en) * 1985-08-12 1987-03-04 Syntex (U.S.A.) Inc. Bovine growth hormone releasing factor derivative
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
NZ238748A (en) * 1990-06-29 1993-09-27 Hoffmann La Roche Growth hormone releasing factor (grf) analogues
DE69108192T2 (en) * 1990-12-10 1995-07-20 Hoffmann La Roche Process for the enzymatic production of GRF (1-44) NH2.
CA2084061A1 (en) * 1991-04-09 1992-10-10 Arthur M. Felix Growth hormone releasing factor analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs

Also Published As

Publication number Publication date
EP0121764A2 (en) 1984-10-17
IL71150A (en) 1987-02-27
AU574064B2 (en) 1988-06-30
JPH0786120B2 (en) 1995-09-20
DK162130B (en) 1991-09-23
IL71150A0 (en) 1984-06-29
DK151884D0 (en) 1984-03-05
DK151884A (en) 1984-09-08
AU2526884A (en) 1984-09-13
EP0121764A3 (en) 1985-12-04
JPS59176238A (en) 1984-10-05
IE840537L (en) 1984-09-07
NZ207378A (en) 1989-05-29
ZA841638B (en) 1984-10-31
CA1254000A (en) 1989-05-09
EP0121764B1 (en) 1990-05-30
ATE53220T1 (en) 1990-06-15
DE3482387D1 (en) 1990-07-05
IE57097B1 (en) 1992-04-22

Similar Documents

Publication Publication Date Title
DK162130C (en) GRF ANALOG PEPTIDES, METHOD FOR PREPARATION THEREOF, GRF ANALOG PEPTIDES AS THERAPEUTICS, USE OF GRF ANALOG PEPTIDES, METHOD FOR MANUFACTURE OF PHARMACEUTICAL PREPARATIONS CONTAINING GRF peptide analogues and intravenous PHARMACEUTICAL PREPARATIONS CONTAINING GRF ANALOG PEPTIDES
DK601786A (en) HIS UNKNOWN PROCOAGULATION PROTEINS
NO912438L (en) HUMANINSULINANALOGER.
DE3852636D1 (en) PEPTIDE ANALOGS FROM INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) OR FACTOR 2 (IGF-2).
DK0910571T3 (en) Novel antiangiogenic peptides, coding polynucleotides, and methods of inhibiting angiogenesis
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
FI892688L (en) Process for the preparation of therapeutically useful oligopeptides with cyclic proline analogs amino acids
DE69029377D1 (en) SUBSTITUTION ANALOGS OF MAGAIN PEPTIDES
ES2015366A6 (en) Elastase inhibiting polypeptides and process for their preparation by genetic recombination.
KR890010202A (en) Vectors and Compounds for Expression of the Simogen Form of Human Protein C
ATE124955T1 (en) SUBSTRATE PEPTIDES.
ATE110389T1 (en) THF COMPOSITIONS.
GB1002041A (en) New polypeptides and process for their manufacture
ATE46173T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
ATE91286T1 (en) VESSEL ACTIVE PEPTIDES.
LI et al. Distinct behavior of β‐endorphin and corticotropin toward leucine aminopeptidase action
ATE106944T1 (en) RECOMBINANT POLYPEPTIDES OF HEMORRHAGIC FISH SEPSIS VIRUS.
CA1267086C (en) Method of administering diuretic atrial peptides
DE59008515D1 (en) New CNS active hexapeptides with anti-amnestic effects.
TH35998A (en) LH-RH Peptide analogues, their benefits and the pharmaceutical constituents they contain.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed